Mariner LLC Has $3.03 Million Stock Holdings in Laboratory Co. of America Holdings (NYSE:LH)

Mariner LLC increased its holdings in shares of Laboratory Co. of America Holdings (NYSE:LH - Free Report) by 25.8% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 13,215 shares of the medical research company's stock after purchasing an additional 2,709 shares during the period. Mariner LLC's holdings in Laboratory Co. of America were worth $3,030,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Graney & King LLC acquired a new position in shares of Laboratory Co. of America during the 4th quarter worth $26,000. Fortitude Family Office LLC grew its position in Laboratory Co. of America by 312.5% during the fourth quarter. Fortitude Family Office LLC now owns 132 shares of the medical research company's stock worth $30,000 after buying an additional 100 shares during the period. Geneos Wealth Management Inc. increased its holdings in Laboratory Co. of America by 309.8% in the fourth quarter. Geneos Wealth Management Inc. now owns 168 shares of the medical research company's stock valued at $39,000 after buying an additional 127 shares in the last quarter. Human Investing LLC acquired a new stake in shares of Laboratory Co. of America during the 4th quarter valued at approximately $39,000. Finally, Heck Capital Advisors LLC purchased a new stake in shares of Laboratory Co. of America during the 4th quarter worth approximately $44,000. 95.94% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other news, Director Kerrii B. Anderson sold 500 shares of Laboratory Co. of America stock in a transaction dated Wednesday, March 5th. The stock was sold at an average price of $255.63, for a total value of $127,815.00. Following the transaction, the director now directly owns 13,166 shares in the company, valued at approximately $3,365,624.58. The trade was a 3.66 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CMO Amy B. Summy sold 226 shares of the stock in a transaction that occurred on Monday, February 24th. The shares were sold at an average price of $250.40, for a total value of $56,590.40. Following the completion of the sale, the chief marketing officer now directly owns 4,544 shares of the company's stock, valued at $1,137,817.60. This represents a 4.74 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 14,258 shares of company stock worth $3,518,177. 0.84% of the stock is currently owned by company insiders.

Laboratory Co. of America Stock Up 0.0 %

NYSE:LH traded up $0.02 during mid-day trading on Friday, reaching $228.60. The stock had a trading volume of 907,300 shares, compared to its average volume of 633,498. Laboratory Co. of America Holdings has a 1-year low of $191.97 and a 1-year high of $258.59. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.44 and a quick ratio of 1.30. The company has a market capitalization of $19.13 billion, a price-to-earnings ratio of 25.92, a price-to-earnings-growth ratio of 1.71 and a beta of 0.99. The stock's 50 day simple moving average is $235.30 and its two-hundred day simple moving average is $235.01.

Laboratory Co. of America (NYSE:LH - Get Free Report) last posted its earnings results on Thursday, February 6th. The medical research company reported $3.45 EPS for the quarter, topping the consensus estimate of $3.40 by $0.05. Laboratory Co. of America had a net margin of 5.73% and a return on equity of 15.29%. Equities analysts anticipate that Laboratory Co. of America Holdings will post 16.01 EPS for the current year.

Laboratory Co. of America Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, June 11th. Stockholders of record on Thursday, May 29th will be issued a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a dividend yield of 1.26%. Laboratory Co. of America's dividend payout ratio is currently 32.65%.

Wall Street Analysts Forecast Growth

A number of research firms have commented on LH. Piper Sandler boosted their target price on Laboratory Co. of America from $240.00 to $260.00 and gave the stock a "neutral" rating in a research report on Monday, February 10th. StockNews.com lowered shares of Laboratory Co. of America from a "buy" rating to a "hold" rating in a research report on Friday, April 18th. UBS Group dropped their target price on shares of Laboratory Co. of America from $293.00 to $286.00 and set a "buy" rating for the company in a report on Tuesday, January 28th. Redburn Atlantic assumed coverage on shares of Laboratory Co. of America in a report on Wednesday, April 2nd. They issued a "buy" rating and a $276.00 price target on the stock. Finally, Barclays dropped their price objective on shares of Laboratory Co. of America from $260.00 to $240.00 and set an "equal weight" rating for the company in a research note on Thursday, April 10th. Four equities research analysts have rated the stock with a hold rating, eleven have given a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $268.77.

Laboratory Co. of America Profile

Labcorp Holdings, Inc engages in providing medical testing services. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.